Selective induction of dendritic cells using granulocyte macrophage-colony stimulating factor, but not fms-like tyrosine kinase receptor 3-ligand, activates thyroglobulin-specific CD4+/CD25+ T cells and suppresses experimental autoimmune thyroiditis

Journal of Immunology

Volumn 170, Issue 11, 2003, Pages 5511-5522

  Vasu, Chenthamarakshan ^a   Dogan, Rukiye Nazan E ^a   Holterman, Mark J ^a   Prabhakar, Bellur S ^a,b  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b UNIVERSITY OF ILLINOIS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; FLT3 LIGAND; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 10; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 4; THYROGLOBULIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; FEMALE; HASHIMOTO DISEASE; IMMUNE RESPONSE; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; TH1 CELL; TH2 CELL;

EID: 0037851960     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.170.11.5511     Document Type: Article

References (59)

1. - dendritic cells to prime Th1/ Th2 cells in vivo. J. Immunol. 167:4345.
2. Wu, L., A. D'Amico, H. Hochrein, M. O'Keeffe, K. Shortman, and K. Lucas. 2001. Development of thymic and splenic dendritic cell populations from different hemopoietic precursors. Blood 98:3376.
3. Hochrein, H., K. Shortman, D. Vremec, B. Scott, P. Hertzog, and M. O'Keeffe. Differential production of IL-12, IFN-α, and IFN-γ by mouse dendritic cell subsets. J. Immunol. 66:5448.
4. low lymphoid-committed precursors. Blood 96:2511.
5. Vremec, D., and K. Shortman. 1997. Dendritic cell subtypes in mouse lymphoid organs: cross-correlation of surface markers, changes with incubation, and differences among thymus, spleen, and lymph nodes. J. Immunol. 159:565.
6. + subclasses of dendritic cells undergo phenotypic and functional maturation in vitro and in vivo. J. Leukocyte Biol. 69:951.
7. - dendritic cells. J. Immunol. 167:4215.
8. - subclasses of dendritic cells direct the development of distinct T helper cells in vivo. J. Exp. Med. 189:587.
9. O'Shea, J. J., and W. E. Paul. 2002. Regulation of Th1 differentiation-controlling the controllers. Nat. Immunol. 3:506.
10. Hochrein, H., K. Shortman, D. Vremec, B. Scott, P. Hertzog, and M. O'Keeffe. 2001. Differential production of IL-12, IFN-α, and IFN-γ by mouse dendritic cell subsets. J. Immunol. 166:5448.
11. Paul, W. E., and R. A. Seder. 1994. Lymphocyte responses and cytokines. Cell 76:241.
12. Chtanova, T., and C. R. Mackay. 2001. T cell effector subsets: extending the Th1/Th2 paradigm. Adv. Immunol. 78:233.
13. Parajuli, P., R. L. Mosley, V. Pisarev, J. Chavez, A. Ulrich, M. Vamey, R. K. Singh, and J. E. Talmadge. 2001. Flt3 ligand and granulocyte-macrophage colony-stimulating factor preferentially expand and stimulate different dendritic and T-cell subsets. Exp. Hematol. 29:1185.
14. Maraskovsky, E., K. Brasel, M. Teepe, E. R. Roux, S. D. Lyman, K. Shortman, and H. J. McKenna. 1996. Dramatic increase in the numbers of functionally mature dendritic cells in Flt3 ligand-treated mice: multiple dendritic cell subpopulations identified. J. Exp. Med. 184:1953.
15. - dendritic cell precursors. J. Immunol. 166:848.
16. O'Keeffe, M., H. Hochrein, D. Vremec, J. Pooley, R. Evans, S. Woulfe, and K. Shortman. 2002. Effects of administration of progenipoietin 1, Flt-3 ligand, granulocyte colony-stimulating factor, and pegylated granulocyte-macrophage colony-stimulating factor on dendritic cell subsets in mice. Blood 99:2122.
17. Daro, E., E. Butz, J. Smith, M. Teepe, C. R. Maliszewski, and H. J. McKenna. 2002. Comparison of the functional properties of murine dendritic cells generated in vivo with flt3 ligand, GM-CSF and flt3 ligand plus GM-CSF. Cytokine 17:119.
18. high murine dendritic cells in vivo: a comparative analysis with Flt3 ligand. J. Immunol. 165:49.
19. Kroemer, G., F. Hirsch, A. Gonzalez-Garcia, and C. Martinez. 1996. Differential involvement of Th1 and Th2 cytokines in autoimmune diseases. Autoimmunity 24:25.
20. + T cells in the pathogenesis of organ-specific autoimmune diseases. Immunol. Today 16:34.
21. Adorini, L., J. C. Guery, and S. Trembleau. 1996. Manipulation of the Th1/Th2 cell balance: an approach to treat human autoimmune diseases? Autoimmunity 23:53.
22. Sugihara, S., H. Fujiwara, and G. M. Shearer. 1993. Autoimmune thyroiditis induced in mice depleted of particular T cell subsets: characterization of thyroiditis-inducing T cell lines and clones derived from thyroid lesions. J. Immunol. 150:683.
23. Stafford, E. A., and N. R. Rose. 2000. Newer insights into the pathogenesis of experimental autoimmune thyroiditis. Int. Rev. Immunol. 19:501.
24. Drugarin, D., S. Negru, A. Koreck, I. Zosin, and C. Cristea. 2000. The pattern of a Th1 cytokine in autoimmune thyroiditis. Immunol. Lett. 71:73.
25. Zhang, W., J. C. Flynn, and Y. C. Kong. 2001. IL-12 prevents tolerance induction with mouse thyroglobulin by priming pathogenic T cells in experimental auto-immune thyroiditis: role of IFN-γ and the costimulatory molecules CD40L and CD28. Cell. Immunol. 208:52.
26. Wang, S. H., J. D. Bretz, E. Phelps, E. Mezosi, P. L. Arscott, S. Utsugi, and J. R. Baker Jr. 2002. A unique combination of inflammatory cytokines enhances apoptosis of thyroid follicular cells and transforms nondestructive to destructive thyroiditis in experimental autoimmune thyroiditis. J. Immunol. 168:2470.
27. Mitsiades, N., V. Poulaki, C. S. Mitsiades, D. A. Koutras, and G. P. Chrousos. 2001. Apoptosis induced by FasL and TRAIL/Apo2L in the pathogenesis of thyroid diseases. Trends Endocrinol. Metab. 12:384.
28. Stassi, G., D. Di Liberto, M. Todaro, A. Zeuner, L. Ricci-Vitiani, A. Stoppacciaro, L. Ruco, F. Farina, G. Zummo, and R. De Maria. 2000. Control of target cell survival in thyroid autoimmunity by T helper cytokines via regulation of apoptotic proteins. Nat. Immunol. 1:483.
29. Braley-Mullen, H., G. C. Sharp, H. Tang, K. Chen, M. Kyriakos, and J. T. Bickel. 1988. Interleukin-12 promotes activation of effector cells that induce a severe destructive granulomatous form of murine experimental autoimmune thyroiditis. Am. J. Pathol. 152:1347.
30. Mignon-Godefroy, K., M. P. Brazillet, O. Rott, and J. Charreire. 1995. Distinctive modulation by IL-4 and IL-10 of the effector function of murine thyroglobulin-primed cells in "transfer-experimental autoimmune thyroiditis." Cell. Immunol. 162:171.
31. Tang, H., G. C. Sharp, K. P. Peterson, and H. Braley-Mullen. 1998. IFN-γdeficient mice develop severe granulomatous experimental autoimmune thyroiditis with eosinophil infiltration in thyroids. J. Immunol. 160:5105.
32. Soos, J. M., O. Stuve, S. Youssef, M. Bravo, H. M. Johnson, H. L. Weiner, and S. S. Zamvil. 2002. Oral type I IFN-γ promotes a Th2 bias and enhances suppression of autoimmune encephalomyelitis by oral glatiramer acetate. J. Immunol. 169:2231.
33. -/- mice. J. Immunol. 167:1720.
34. Zhang, W., and Y. C. Kong. 1998. Noninvolvement of IL-4 and IL-10 in tolerance induction to experimental autoimmune thyroiditis. Cell. Immunol. 187:95.
35. Zaccone, P., P. Hutchings, F. Nicoletti, G. Penna, L. Adorini, and A. Cooke. 1999. The involvement of IL-12 in murine experimentally induced autoimmune thyroid disease. Eur. J. Immunol. 29:1933.
36. Lafaille, J. J., F. V. Keere, A. L. Hsu, J. L. Baron, W. Haas, C. S. Raine, and S. Tonegawa. 1997. Myelin basic protein-specific T helper 2 (Th2) cells cause experimental autoimmune encephalomyelitis in immunodeficient hosts rather than protect them from the disease. J. Exp. Med. 186:307.
37. Krakowski, M., and T. Owens. 1996. Interferon-γ confers resistance to experimental allergic encephalomyelitis. Eur. J. Immunol. 26:1641.
38. Ferber, I. A., S. Brocke, C. Taylor-Edwards, W. Ridgway, C. Dinisco, L. Steinman, D. Dalton, and C. G. Fathman. 1996. Mice with a disrupted IFN-γ gene are susceptible to the induction of experimental autoimmune encephalomyelitis (EAE). J. Immunol. 156:5.
39. Caturegli, P., M. Hejazi, K. Suzuki, O. Dohan, N. Carrasco, L. D. Kohn, and N. R. Rose. 2000. Hypothyroidism in transgenic mice expressing IFN-γ in the thyroid. Proc. Natl. Acad. Sci. USA 97:1719.
40. + suppressor cells of autoimmune encephalomyelitis respond to T cell receptor-associated determinants on effector cells by interleukin-4 secretion. Eur. J. Immunol. 22:1757.
41. Inobe, J., A. J. Slavin, Y. Komagata, Y. Chen, L. Liu, and H. L. Weiner. 1998. IL-4 is a differentiation factor for transforming growth factor-β secreting Th3 cells and oral administration of IL-4 enhances oral tolerance in experimental allergic encephalomyelitis. Eur. J. Immunol. 28:2780.
42. Croxford J. L., M. Feldmann, Y. Chernajovsky, and D. Baker. 2001. Different therapeutic outcomes in experimental allergic encephalomyelitis dependent upon the mode of delivery of IL-10: a comparison of the effects of protein, adenoviral or retroviral IL-10 delivery into the central nervous system. J. Immunol. 166:4124.
43. Tang, H., G. C. Sharp, K. E. Peterson, and H. Braley-Mullen. 1998. Induction of granulomatous experimental autoimmune thyroiditis in IL-4 gene-disrupted mice. J. Immunol. 160:155.
44. h4 mice. J. Immunol. 169:3999.
45. El Rehewy, M., Y. M. Kong, A. A. Giraldo, and N. R. Rose. 1981. Syngeneic thyroglobulin is immunogenic in good responder mice. Eur. J. Immunol. 11:146.
46. Averbook, B. J., J. L. Schuh, R. Papay, and C. Maliszewski. 2002. Antitumor effects of Flt3 ligand in transplanted murine tumor models. J. Immunother. 25:27.
47. +) dendritic cells: association with conversion from liver transplant tolerance to acute rejection. Transplantation 69:2647.
48. Kremer, I. B., M. P. Gould, K. D. Cooper, and F. P. Heinzel. 2001. Pretreatment with recombinant Flt3 ligand partially protects against progressive cutaneous leishmaniasis in susceptible BALB/c mice. Infect. Immun. 69:673.
49. Garside, P., E. Ingulli, R. R. Merica, J. G. Johnson, R. J. Noelle, and M. K. Jenkins. 1998. Visualization of specific B and T lymphocyte interactions in the lymph node. Science 281:96.
50. + regulatory T cells is mediated by cell surface-bound transforming growth factor β. J. Exp. Med. 194:629.
51. + T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells. J. Exp. Med. 192:1213.
52. + regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance. Immunol. Rev. 182:18.
53. + regulatory T cells by oral antigen administration. J. Immunol. 167:4245.
54. Tourneur, L., D. Damotte, S. Marion, S. Mistou, and G. Chiocchia. 2002. IL-10 is necessary for FasL-induced protection from experimental autoimmune thyroiditis but not for FasL-induced immune deviation. Eur. J. Immunol. 32:1292.
55. Batteux, F., H. Trebeden, J. Charreire, and G. Chiocchia. 1999. Curative treatment of experimental autoimmune thyroiditis by in vivo administration of plasmid DNA coding for interleukin-10. Eur. J. Immunol. 29:958.
56. Alimi, E., S. Huang, M. P. Brazillet, and J. Charreire. 1998. Experimental autoimmune thyroiditis (EAT) in mice lacking the IFN-γ receptor gene. Eur. J. Immunol. 28:201.
57. Tang, H., K. Mignon-Godefroy, P. L. Meroni, G. Garotta, J. Charreire, and F. Nicoletti. 1993. The effects of a monoclonal antibody to interferon-γ on experimental autoimmune thyroiditis (EAT): prevention of disease and decrease of EAT-specific T cells. Eur. J. Immunol. 23:275.
58. Vasu, C., S. R. Gorla, B. S. Prabhakar, and M. J. Holterman. 2003. Targeted engagement of CTLA-4 prevents autoimmune thyroiditis. Int. Immunol. 15:641.
59. Dogan, R. N., C. Vasu, M. J. Holterman, and B. S. Prabhakar. 2003. Absence of IL-4, and not suppression of the Th2 response, prevents development of experimental autoimmune Graves' disease. J. Immunol. 170:2195.